8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Plasmodium falciparum erythrocyte membrane protein 1 variants induce cell swelling and disrupt the blood–brain barrier in cerebral malaria

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Plasmodium falciparum parasites causing cerebral malaria express specific PfEMP1 proteins (group A +CM) on infected erythrocytes. Group A +CM PfEMP1s allow entry into brain microvascular endothelial cells; this causes cell swelling and drives cerebral malaria pathology by disrupting the blood–brain barrier.

          Abstract

          Cerebral malaria (CM) is caused by the binding of Plasmodium falciparum–infected erythrocytes (IEs) to the brain microvasculature, leading to inflammation, vessel occlusion, and cerebral swelling. We have previously linked dual intercellular adhesion molecule-1 (ICAM-1)– and endothelial protein C receptor (EPCR)–binding P. falciparum parasites to these symptoms, but the mechanism driving the pathogenesis has not been identified. Here, we used a 3D spheroid model of the blood–brain barrier (BBB) to determine unexpected new features of IEs expressing the dual-receptor binding PfEMP1 parasite proteins. Analysis of multiple parasite lines shows that IEs are taken up by brain endothelial cells in an ICAM-1–dependent manner, resulting in breakdown of the BBB and swelling of the endothelial cells. Via ex vivo analysis of postmortem tissue samples from CM patients, we confirmed the presence of parasites within brain endothelial cells. Importantly, this discovery points to parasite ingress into the brain endothelium as a contributing factor to the pathology of human CM.

          Graphical Abstract

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Fiji: an open-source platform for biological-image analysis.

          Fiji is a distribution of the popular open-source software ImageJ focused on biological-image analysis. Fiji uses modern software engineering practices to combine powerful software libraries with a broad range of scripting languages to enable rapid prototyping of image-processing algorithms. Fiji facilitates the transformation of new algorithms into ImageJ plugins that can be shared with end users through an integrated update system. We propose Fiji as a platform for productive collaboration between computer science and biology research communities.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tissue Plasminogen Activator for Acute Ischemic Stroke

            (1996)
            Thrombolytic therapy for acute ischemic stroke has been approached cautiously because there were high rates of intracerebral hemorrhage in early clinical trials. We performed a randomized, double-blind trial of intravenous recombinant tissue plasminogen activator (t-PA) for ischemic stroke after recent pilot studies suggested that t-PA was beneficial when treatment was begun within three hours of the onset of stroke. The trial had two parts. Part 1 (in which 291 patients were enrolled) tested whether t-PA had clinical activity, as indicated by an improvement of 4 points over base-line values in the score of the National Institutes of Health stroke scale (NIHSS) or the resolution of the neurologic deficit within 24 hours of the onset of stroke. Part 2 (in which 333 patients were enrolled) used a global test statistic to assess clinical outcome at three months, according to scores on the Barthel index, modified Rankin scale, Glasgow outcome scale, and NIHSS: In part 1, there was no significant difference between the group given t-PA and that given placebo in the percentages of patients with neurologic improvement at 24 hours, although a benefit was observed for the t-PA group at three months for all four outcome measures. In part 2, the long-term clinical benefit of t-PA predicted by the results of part 1 was confirmed (global odds ratio for a favorable outcome, 1.7; 95 percent confidence interval, 1.2 to 2.6). As compared with patients given placebo, patients treated with t-PA were at least 30 percent more likely to have minimal or no disability at three months on the assessment scales. Symptomatic intracerebral hemorrhage within 36 hours after the onset of stroke occurred in 6.4 percent of patients given t-PA but only 0.6 percent of patients given placebo (P < 0.001). Mortality at three months was 17 percent in the t-PA group and 21 percent in the placebo group (P = 0.30). Despite an increased incidence of symptomatic intracerebral hemorrhage, treatment with intravenous t-PA within three hours of the onset of ischemic stroke improved clinical outcome at three months.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Genome sequence of the human malaria parasite Plasmodium falciparum.

              The parasite Plasmodium falciparum is responsible for hundreds of millions of cases of malaria, and kills more than one million African children annually. Here we report an analysis of the genome sequence of P. falciparum clone 3D7. The 23-megabase nuclear genome consists of 14 chromosomes, encodes about 5,300 genes, and is the most (A + T)-rich genome sequenced to date. Genes involved in antigenic variation are concentrated in the subtelomeric regions of the chromosomes. Compared to the genomes of free-living eukaryotic microbes, the genome of this intracellular parasite encodes fewer enzymes and transporters, but a large proportion of genes are devoted to immune evasion and host-parasite interactions. Many nuclear-encoded proteins are targeted to the apicoplast, an organelle involved in fatty-acid and isoprenoid metabolism. The genome sequence provides the foundation for future studies of this organism, and is being exploited in the search for new drugs and vaccines to fight malaria.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: ResourcesRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: InvestigationRole: Writing - review & editing
                Role: Data curationRole: InvestigationRole: Methodology
                Role: Formal analysisRole: Investigation
                Role: Methodology
                Role: ResourcesRole: ValidationRole: Writing - review & editing
                Role: InvestigationRole: Resources
                Role: InvestigationRole: Resources
                Role: InvestigationRole: MethodologyRole: Writing - original draft
                Role: InvestigationRole: Writing - review & editing
                Role: Funding acquisitionRole: InvestigationRole: ResourcesRole: Writing - original draft
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Journal
                J Exp Med
                J Exp Med
                jem
                The Journal of Experimental Medicine
                Rockefeller University Press
                0022-1007
                1540-9538
                01 March 2021
                25 January 2021
                25 January 2021
                : 218
                : 3
                : e20201266
                Affiliations
                [1 ]Centre for Medical Parasitology at Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
                [2 ]Brigham and Women’s Hospital, Boston, MA
                [3 ]Harvard Medical School, Boston, MA
                [4 ]Department of Pathology, Ispat General Hospital, Rourkela, India
                [5 ]Center for the Study of Complex Malaria in India, Ispat General Hospital, Rourkela, India
                [6 ]Core Facility for Integrated Microscopy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
                [7 ]Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK
                Author notes
                Correspondence to Anja T.R. Jensen: atrj@ 123456sund.ku.dk

                A. Bengtsson’s present address is Gubra, Hørsholm, Denmark.

                S. Satpathi’s present address is Hitech Medical College and Hospital, Rourkela, India.

                Author information
                https://orcid.org/0000-0001-8041-6580
                https://orcid.org/0000-0003-4034-4302
                https://orcid.org/0000-0001-9523-8369
                https://orcid.org/0000-0002-2584-9639
                https://orcid.org/0000-0002-4275-2724
                https://orcid.org/0000-0003-0519-6199
                https://orcid.org/0000-0002-5435-3325
                https://orcid.org/0000-0001-7855-7501
                https://orcid.org/0000-0002-1633-2339
                https://orcid.org/0000-0001-8811-0260
                https://orcid.org/0000-0002-6753-3376
                https://orcid.org/0000-0002-4004-7554
                Article
                jem.20201266
                10.1084/jem.20201266
                7833209
                33492344
                7b2c709d-0c78-4963-82d3-1f4111f0686e
                © 2021 Adams et al.

                This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

                History
                : 19 June 2020
                : 11 November 2020
                : 11 December 2020
                Page count
                Pages: 13
                Funding
                Funded by: Augustinus Fonden, DOI http://dx.doi.org/10.13039/501100004954;
                Funded by: Aase og Ejnar Danielsen Fond, DOI http://dx.doi.org/10.13039/501100003035;
                Funded by: AP Møller Fonden;
                Award ID: 18-L-0040
                Funded by: Hørslev Fonden, DOI http://dx.doi.org/10.13039/100008733;
                Award ID: 203866-MAS/mbs1
                Funded by: Independent Research Fund Denmark, DOI http://dx.doi.org/10.13039/501100004836;
                Award ID: 8020-00034B
                Funded by: Lundbeck Foundation, DOI http://dx.doi.org/10.13039/501100003554;
                Award ID: R180-2014-3098
                Award ID: R324-2019-2029
                Award ID: R313-2019-322
                Funded by: Læge Sofus Carl Emil Friis og hustru Olga Doris Friis´ Legat, DOI http://dx.doi.org/10.13039/501100008269;
                Funded by: Novo Nordisk Fonden, DOI http://dx.doi.org/10.13039/501100009708;
                Award ID: NNF16OC0022298
                Funded by: Svend Andersen Fonden, DOI http://dx.doi.org/10.13039/501100007371;
                Funded by: Consultative Committee for Developmental Research;
                Award ID: 17-02-KU
                Funded by: National Institutes of Health, DOI http://dx.doi.org/10.13039/100000002;
                Award ID: RO1CA237063
                Funded by: National Institutes of Health, DOI http://dx.doi.org/10.13039/100000002;
                Award ID: U19AI089676
                Funded by: Medical Research Council, DOI http://dx.doi.org/10.13039/501100000265;
                Award ID: MR/S009450/1
                Categories
                Article
                Infectious Disease and Host Defense

                Medicine
                Medicine

                Comments

                Comment on this article